Home MannKind's Afrezza Remains in Sanofi's Plans, RBC Says
 

Keywords :   


MannKind's Afrezza Remains in Sanofi's Plans, RBC Says

2014-11-22 19:25:26| Biotech - Topix.net

Yesterday, Sanofi hosted a seminar on new medicines in Cambridge, Mass., and RBC's Adnan Butt and team note that MannKind's inhaled insulin Afrezza "featured prominently enough." They summarize the highlights of the presentation: MannKind's partner reiterated prior guidance that a commercial launch is planned for 1Q:15.

Tags: plans says remains rbc

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »